Global Health Leaders Unite Behind Landmark AI Equity Pledge at Seoul Summit

South Korea's Ministry of Health and Welfare and the World Health Organization have jointly issued an international commitment to ensure artificial intelligence benefits all populations equally, regardless of wealth or geography. The "Seoul Declaration on AI in Healthcare," unveiled at the 2026 World Bio Summit in Seoul, establishes core principles for deploying medical AI responsibly while addressing what organizers describe as healthcare's most intractable challenges.

The declaration comes as AI technologies rapidly transform clinical practice in wealthy nations, raising concerns that low- and middle-income countries could be left further behind in accessing cutting-edge diagnostics, treatment optimization, and preventive care innovations.

A Framework for Responsible Innovation

Minister of Health and Welfare Jeong Eun-kyeong and WHO Director-General Tedros Adhanom Ghebreyesus jointly presented the declaration at COEX Magok during the two-day summit held Wednesday and Thursday. The document establishes three foundational principles: safe and responsible AI use, strengthening global solidarity, and equitable access to AI innovation benefits.

The International Hospital Federation, represented by President Henry Gallardo, formally endorsed the declaration, signaling buy-in from healthcare delivery organizations worldwide. The summit's "Leaders' Dialogue" focused specifically on responsible and inclusive healthcare AI, while three breakout sessions examined AI's future science, value creation potential, and financing mechanisms.

The World Bio Summit has been co-hosted annually by the South Korean government and WHO since 2022, originally concentrating on infectious disease response and global health security before expanding to encompass broader health technology governance.

From Principles to Practice

Eight side events during the summit brought together diverse stakeholders including the Cross-Ministry Integrated Healthcare Association, GC Biopharma Medical Foundation, Korea In Vitro Diagnostics Association, KDCA, CEPI, the Gates Foundation, Brunei's Ministry of Health, and the Asian Development Bank. Discussions ranged from diagnostic device access expansion and pandemic preparedness to health public goods for low- and middle-income countries, smart hospitals, ESG management, and vaccination policy.

For healthcare providers, the declaration signals increasing international standardization of medical AI governance, requiring alignment with principles of equitable access and responsible deployment. Clinical practices will need frameworks for implementing AI that prioritize patient safety and dignity.

Health technology companies face new expectations to design solutions accessible across socioeconomic barriers, potentially influencing regulatory requirements, reimbursement models, and market access strategies in signatory nations. The declaration establishes that developers must demonstrate commitment to equitable distribution and responsible innovation.

The Implementation Challenge

While the Seoul Declaration articulates ambitious goals for preventing AI benefits from being monopolized by wealthy populations, the mechanisms for translating these principles into practice remain to be defined. The declaration positions AI as a tool capable of solving healthcare's hardest problems, but achieving "AI-based universal healthcare" will require sustained international cooperation, financing commitments, and accountability structures that extend beyond aspirational statements.

The coming months will reveal whether this international commitment represents a genuine turning point in global health AI governance or remains primarily symbolic without enforceable implementation pathways.

Sources

1. AI can solve healthcare's hardest problems — but the world must act together — The Herald Business